For Q1 FY2026 ending September, net sales were JPY 15,897 million (22.3% YoY increase), operating income was JPY 2,786 million (122.4% YoY increase), and net income attributable to owners of parent was JPY 324 million (67.2% YoY decrease).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4554","jir_company_name":"Fuji Pharmaceutical Industrial Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-02-05","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/4554-20260205-01.pdf","jir_short_summary":"For Q1 FY2026 ending September, net sales were JPY 15,897 million (22.3% YoY increase), operating income was JPY 2,786 million (122.4% YoY increase), and net income attributable to owners of parent was JPY 324 million (67.2% YoY decrease).","jir_summary":"### Overview of Business Performance\nConsolidated net sales for Q1 FY2026 ending September were JPY 15,897 million (22.3% YoY increase), primarily driven by steady performance of new drugs in the 'Women's Healthcare' segment. Operating income rose significantly to JPY 2,786 million (122.4% YoY increase), reflecting an increase in gross profit due to higher sales, which absorbed increased R&D expenses and depreciation costs. On the other hand, net income attributable to owners of parent decreased to JPY 324 million (67.2% YoY decrease), impacted by the recording of investment securities valuation losses.\n\n### Financial Position and Earnings Guidance\nTotal assets stood at JPY 95,080 million (an increase of JPY 1,675 million from the end of the previous period), and net assets were JPY 47,952 million (up JPY 1,044 million), with a stable equity ratio of 50.4%, maintaining a sound financial base. The number of shares issued was 24,891,100, with treasury shares totaling 421,339. The full-year earnings forecast for FY2026 ending September anticipates net sales of JPY 59,250 million (14.7% YoY increase), operating income of JPY 6,120 million (22.6% YoY increase), and net income attributable to owners of parent of JPY 2,240 million (25.3% YoY decrease).","jir_financial_highlights":"Net Sales: JPY 15,897 million (22.3% YoY increase)\nOperating Income: JPY 2,786 million (122.4% YoY increase)\nOrdinary Income: JPY 2,653 million (92.8% YoY increase)\nNet Income Attributable to Owners of Parent: JPY 324 million (67.2% YoY decrease)\nTotal Assets: JPY 95,080 million (Increase of JPY 1,675 million from previous consolidated fiscal year-end)\nNet Assets: JPY 47,952 million (Increase of JPY 1,044 million from previous consolidated fiscal year-end)\nEquity Ratio: 50.4% (Increase of 0.2 points from previous consolidated fiscal year-end)\nNumber of Shares Issued (Common Stock) at Period-End: 24,891,100 shares (Unknown)\nNumber of Treasury Shares at Period-End: 421,339 shares (Decrease from 435,865 shares at previous consolidated fiscal year-end)","jir_category":"","jir_hashtags":"#FujiPharmaceuticalIndustrial, #FinancialSummary, #JapaneseStocks","jir_key_figures":"Net Sales: JPY 15,897 million (22.3% YoY increase)\nOperating Income: JPY 2,786 million (122.4% YoY increase)\nNet Income Attributable to Owners of Parent for the Quarter: JPY 324 million (67.2% YoY decrease)","jir_meta_title":"Fuji Pharmaceutical Industrial Q1 FY2026 Financial Summary Net Sales JPY 15,897 million 22.3% Increase","jir_meta_description":"Fuji Pharmaceutical Industrial Q1 FY2026 Financial Summary. Net sales JPY 15,897 million (22.3% YoY increase), operating income JPY 2,786 million (122.4% YoY increase), net income JPY 324 million (67.2% YoY decrease). Includes stable financial base and full-year earnings forecast.","jir_og_title":"Fuji Pharmaceutical Industrial Q1 FY2026 Financial Results Announcement","jir_og_description":"Net sales of JPY 15,897 million and operating income of JPY 2,786 million. Net income declined due to investment valuation losses. Maintains a stable financial foundation.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Net Sales Trend (Million JPY)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q1 FY2025\\\",\\\"Q1 FY2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[13000,15897],\\\"backgroundColor\\\":\\\"#4e79a7\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Operating Income Trend (Million JPY)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q1 FY2025\\\",\\\"Q1 FY2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Income\\\",\\\"data\\\":[1252,2786],\\\"backgroundColor\\\":\\\"#f28e2b\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}, {\"jir_chart_id\": \"net_profit_trend\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Net Income Attributable to Owners of Parent Trend (Million JPY)\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"bar\\\",\\\"data\\\":{\\\"labels\\\":[\\\"Q1 FY2025\\\",\\\"Q1 FY2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Income\\\",\\\"data\\\":[991,324],\\\"backgroundColor\\\":\\\"#e15759\\\"}]},\\\"options\\\":{\\\"scales\\\":{\\\"y\\\":{\\\"beginAtZero\\\":true}}}}\"}]","ir_related_company":17504,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-24825","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n